biotech

Thermo Fisher Scientific (TMO): Quality Franchise, Price Debate

Thermo Fisher Scientific remains a top-tier life sciences platform with recurring revenue, strong cash flow, and multiple growth catalysts. The stock is a Buy, but the report argues the main question is valuation rather than business quality.